Publications

How useful are inflammatory marker tests in primary care?

ARC BITE

Millions of inflammatory marker tests are ordered by GPs in England each year and rates of testing are rising. Many of these tests will be done appropriately, but GPs are increasingly using them as a non-specific test to rule out serious underlying disease. Until now there has been no evidence about whether this is a good strategy.

Read How useful are inflammatory marker tests in primary care?

How shoulder surgery demonstrates the need to improve evaluation of surgical procedures

ARC BITE

The UK has strict regulations to ensure new medicines work and are cost-effective before they are recommended for use in the NHS. However, surgical procedures are less strictly regulated. This study used a type of surgery for shoulder pain called subacromial decompression as a case study to explore the relationship between evolving evidence and clinical practice, to illustrate the need for better evaluation of surgical procedures.

Read How shoulder surgery demonstrates the need to improve evaluation of surgical procedures

ARC West email newsletter – October 2019

NEWSLETTER

The email newsletter from ARC West. In this edition: John Macleod’s hopes for ARC West; Domestic violence and abuse: how NIHR research is helping families; Surgical procedures need better evaluation; Plus much more

Read ARC West email newsletter – October 2019

Telephone outreach to increase NHS Health Checks among deprived and ethnic minority communities

ARC BITE

In Bristol, telephone outreach has been used to encourage people in more deprived communities and minority ethnic groups to attend NHS Health Checks, with community outreach workers based in GP practices phoning patients. Through in-depth interviews, this study examined the views and experiences of both patients and staff of this telephone outreach approach. We wanted to find out how the intervention was delivered by the outreach workers, how the patients found it and the impact it had.

Read Telephone outreach to increase NHS Health Checks among deprived and ethnic minority communities

Best of CLAHRC West

ABOUT ARC

The Best of CLAHRC West highlights some of the applied research projects we’ve worked on over the five years we were operating as NIHR CLAHRC West.

Read Best of CLAHRC West

CLAHRC West newsletter 1 July 2019

NEWSLETTER

In this edition: The Best of CLAHRC West; Lack of evidence in guidelines for monitoring chronic diseases; GPs should not use inflammatory marker tests to rule out serious conditions

Read CLAHRC West newsletter 1 July 2019

3D study: Managing multimorbidity in primary care

ARC BITE

The 3D study was the largest ever trial of an intervention for people with multimorbidity, with 1,546 patients recruited. It was a randomised control trial, the best test of any medical intervention. It evaluated a patient-centred intervention, the 3D approach, to improve how GP practices manage and care for patients with multimorbidity.

Read 3D study: Managing multimorbidity in primary care

Overcoming Barriers: Autism in the Somali Community

ARC BITE

Overcoming Barriers is a short film exploring perceptions of autism in the Somali community and the experiences of parents accessing support for their children. Their stories are interwoven with the perspectives of professionals from health, social care and education who support these families.

Read Overcoming Barriers: Autism in the Somali Community

Preventing post-operative urinary retention

ARC BITE

We reviewed the literature to identify the factors influencing whether a patient will develop urinary retention and what can be done to prevent and treat it.

Read Preventing post-operative urinary retention

Investigating a single blood test to screen for prostate cancer (the CAP trial)

ARC BITE

The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) study aimed to see if inviting men to have a single PSA blood test would reduce the number of men dying from prostate cancer.

Read Investigating a single blood test to screen for prostate cancer (the CAP trial)